New drug trial offers hope for painful skin condition
NCT ID NCT07287644
Summary
This study is testing whether an investigational drug called BFB759 can reduce painful skin lesions and improve quality of life for people with moderate to severe hidradenitis suppurativa (HS). About 210 adults whose HS isn't well controlled by antibiotics will receive either BFB759 or a placebo for about 9-10 months. Researchers will measure changes in lesion counts, pain levels, and overall disease severity to see if the drug works better than the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trials Management, LLC
RECRUITINGTampa, Florida, 33607, United States
-
Clinical Trials Management, LLC
RECRUITINGMetairie, Louisiana, 70006, United States
-
Skin Care Research
RECRUITINGBoca Raton, Florida, 33021, United States
-
Ziaderm Research LLC
RECRUITINGNorth Miami Beach, Florida, 33126, United States
Conditions
Explore the condition pages connected to this study.